Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Fish and Richardson
Accenture
Chinese Patent Office
Farmers Insurance
Mallinckrodt
Johnson and Johnson
Cantor Fitzgerald
Teva

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020506

« Back to Dashboard

NDA 020506 describes TIAMATE, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the TIAMATE profile page.

The generic ingredient in TIAMATE is diltiazem malate. There are twenty-six drug master file entries for this compound. Additional details are available on the diltiazem malate profile page.
Summary for 020506
Tradename:TIAMATE
Applicant:Merck
Ingredient:diltiazem malate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 120MG HCL
Approval Date:Oct 4, 1996TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 180MG HCL
Approval Date:Oct 4, 1996TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 240MG HCL
Approval Date:Oct 4, 1996TE:RLD:No

Expired US Patents for NDA 020506

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-002 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-003 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-003 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Dow
Boehringer Ingelheim
Chinese Patent Office
Citi
Covington
McKinsey
Daiichi Sankyo
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.